Cartesian Therapeutics Inc.: Mizuho sets purchase rating and target share price of $40 for the first time
Cartesian Therapeutics Inc：瑞穗首次设定买入评级和40美元的目标股价
Cartesian Therapeutics Inc.: Mizuho sets purchase rating and target share price of $40 for the first time
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.